Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 315

1.

Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients.

Gayraud M, Guillevin L, le Toumelin P, Cohen P, Lhote F, Casassus P, Jarrousse B; French Vasculitis Study Group.

Arthritis Rheum. 2001 Mar;44(3):666-75.

2.

Deaths occurring during the first year after treatment onset for polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: a retrospective analysis of causes and factors predictive of mortality based on 595 patients.

Bourgarit A, Le Toumelin P, Pagnoux C, Cohen P, Mahr A, Le Guern V, Mouthon L, Guillevin L; French Vasculitis Study Group.

Medicine (Baltimore). 2005 Sep;84(5):323-30.

3.
4.

Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients.

Guillevin L, Lhote F, Gayraud M, Cohen P, Jarrousse B, Lortholary O, Thibult N, Casassus P.

Medicine (Baltimore). 1996 Jan;75(1):17-28.

6.

Treatment of polyarteritis nodosa and microscopic polyangiitis without poor-prognosis factors: A prospective randomized study of one hundred twenty-four patients.

Ribi C, Cohen P, Pagnoux C, Mahr A, Arène JP, Puéchal X, Carli P, Kyndt X, Le Hello C, Letellier P, Cordier JF, Guillevin L; French Vasculitis Study Group.

Arthritis Rheum. 2010 Apr;62(4):1186-97. doi: 10.1002/art.27340.

7.

Treatment of Churg-Strauss syndrome without poor-prognosis factors: a multicenter, prospective, randomized, open-label study of seventy-two patients.

Ribi C, Cohen P, Pagnoux C, Mahr A, Arène JP, Lauque D, Puéchal X, Letellier P, Delaval P, Cordier JF, Guillevin L; French Vasculitis Study Group.

Arthritis Rheum. 2008 Feb;58(2):586-94. doi: 10.1002/art.23198.

8.
9.

Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients.

Guillevin L, Mahr A, Callard P, Godmer P, Pagnoux C, Leray E, Cohen P; French Vasculitis Study Group.

Medicine (Baltimore). 2005 Sep;84(5):313-22.

10.

Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patients.

Guillevin L, Cohen P, Mahr A, Arène JP, Mouthon L, Puéchal X, Pertuiset E, Gilson B, Hamidou M, Lanoux P, Bruet A, Ruivard M, Vanhille P, Cordier JF.

Arthritis Rheum. 2003 Feb 15;49(1):93-100.

11.

The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort.

Guillevin L, Pagnoux C, Seror R, Mahr A, Mouthon L, Le Toumelin P; French Vasculitis Study Group (FVSG).

Medicine (Baltimore). 2011 Jan;90(1):19-27. doi: 10.1097/MD.0b013e318205a4c6.

12.

Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database.

Pagnoux C, Seror R, Henegar C, Mahr A, Cohen P, Le Guern V, Bienvenu B, Mouthon L, Guillevin L; French Vasculitis Study Group.

Arthritis Rheum. 2010 Feb;62(2):616-26. doi: 10.1002/art.27240.

13.

Primary systemic vasculitis: clinical features and mortality.

Lane SE, Watts RA, Shepstone L, Scott DG.

QJM. 2005 Feb;98(2):97-111. Epub 2005 Jan 17.

PMID:
15655098
14.

High frequency of venous thromboembolic events in Churg-Strauss syndrome, Wegener's granulomatosis and microscopic polyangiitis but not polyarteritis nodosa: a systematic retrospective study on 1130 patients.

Allenbach Y, Seror R, Pagnoux C, Teixeira L, Guilpain P, Guillevin L; French Vasculitis Study Group.

Ann Rheum Dis. 2009 Apr;68(4):564-7. doi: 10.1136/ard.2008.099051. Epub 2008 Nov 17.

PMID:
19015208
15.

Incidence and survival rates in Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa.

Mohammad AJ, Jacobsson LT, Westman KW, Sturfelt G, Segelmark M.

Rheumatology (Oxford). 2009 Dec;48(12):1560-5. doi: 10.1093/rheumatology/kep304. Epub 2009 Oct 1.

PMID:
19797309
16.
17.

Mortality and morbidity in peripheral neuropathy associated Churg-Strauss syndrome and microscopic polyangiitis.

Hattori N, Mori K, Misu K, Koike H, Ichimura M, Sobue G.

J Rheumatol. 2002 Jul;29(7):1408-14.

PMID:
12136898
18.

Prevalence of Wegener's granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome within a defined population in southern Sweden.

Mohammad AJ, Jacobsson LT, Mahr AD, Sturfelt G, Segelmark M.

Rheumatology (Oxford). 2007 Aug;46(8):1329-37. Epub 2007 Jun 6.

PMID:
17553910
19.

Outcome of polyarteritis nodosa and Churg-Strauss syndrome. An analysis of twenty-five patients.

Abu-Shakra M, Smythe H, Lewtas J, Badley E, Weber D, Keystone E.

Arthritis Rheum. 1994 Dec;37(12):1798-803.

PMID:
7986227
20.

Microscopic polyangiitis and polyarteritis nodosa: how and when do they start?

Agard C, Mouthon L, Mahr A, Guillevin L.

Arthritis Rheum. 2003 Oct 15;49(5):709-15.

Supplemental Content

Support Center